Mark Haydock

CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies

K. Pienta, S. Almo, P. Kiener, 2020, Clinical Cancer Research.